Last updated on March 2018

Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy)


Brief description of study

Prospective, Double-blind, Randomized, Placebo-Controlled Phase III Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis ("ProDERM study")

Clinical Study Identifier: NCT02728752

Contact Investigators or Research Sites near you

Start Over

Mikaela Grupp

Octapharma Research Site
Phoenix, AZ United States
  Connect »

Mikaela Grupp

Octapharma Research Site
Kansas City, KS United States
  Connect »

Mikaela Grupp

Octapharma Research Site
Ann Arbor, MI United States
  Connect »

Mikaela Grupp

Octapharma Research Site
Great Neck, NY United States
  Connect »

Mikaela Grupp

Octapharma Research Site
Columbus, OH United States
  Connect »

Mikaela Grupp

Octapharma Research Site
Portland, OR United States
  Connect »

Mikaela Grupp

Octapharma Research Site
Pittsburgh, PA United States
  Connect »

Mikaela Grupp

Revmatologick stav
Praha, Czechia
  Connect »

Mikaela Grupp

Service de M decine Interne 2 Centre National de R f rence Maladies Auto-Immunes Syst miques Rares Intitut E3M
Paris, France
  Connect »

Mikaela Grupp

C.H.U. de Touen-H pital Charles Nicolle Deaprtment de M decine Interne
Rouen, France
  Connect »

Mikaela Grupp

Service de M decine Interne Batiment URM
Toulouse, France
  Connect »

Mikaela Grupp

Charit -Universit tsmedizin Berlin, Klinik f r Dermatologie, Venerologie und Allergologie
Berlin, Germany
  Connect »

Mikaela Grupp

Unimedizin Mainz, Unihautklinik
Mainz, Germany
  Connect »

Mikaela Grupp

University of Debrecen Dept of Internal Medicine
Debrecen, Hungary
  Connect »

Mikaela Grupp

University of Szeged Dermatology Clinic
Szeged, Hungary
  Connect »

Mikaela Grupp

Narodowy Instytut Geriatrii, Reumatologii I Rehabilitacji - Warsaw
Warsaw, Poland
  Connect »

Mikaela Grupp

AVA-Peter clinic (Saint-Petersburg)
Saint Petersburg, Russian Federation
  Connect »

Mikaela Grupp

State Budgetary Healthcare Institution of Samara Region "Tolyatti City Clinical Hospital # 5"
Tolyatti, Russian Federation
  Connect »

Mikaela Grupp

Octapharma Research Site
Los Angeles, CA United States
  Connect »

Mikaela Grupp

Uniklinikum Heidelberg, Hautklinik
Heidelberg, Germany
  Connect »

Mikaela Grupp

Semmelweis University Dermatology Clinic
Budapest, Hungary
  Connect »

Mikaela Grupp

Scientific Research Institute for Rheumatology (Moscow)
Moscow, Russian Federation
  Connect »

Mikaela Grupp

I.M. Sechenov First Moscow State Medical University
Moscow, Russian Federation
  Connect »

Mikaela Grupp

Octapharma Research Site
Birmingham, AL United States
  Connect »

Mikaela Grupp

University of California -Irvine
Orange, CA United States
  Connect »

Mikaela Grupp

L&C Professional Medical Research Institute
Miami, FL United States
  Connect »

Mikaela Grupp

NeuroMedical Research Center
Panama City, FL United States
  Connect »

Mikaela Grupp

University of South Florida
Tampa, FL United States
  Connect »

Mikaela Grupp

Stones River Dermatology
Murfreesboro, TN United States
  Connect »

Mikaela Grupp

Amarillo Center for Clinical Research
Amarillo, TX United States
  Connect »

Mikaela Grupp

Austin Neuromuscular Center
Austin, TX United States
  Connect »

Mikaela Grupp

BI Research Center
Houston, TX United States
  Connect »

Mikaela Grupp

Arthritis & Osteoporosis Clinic
Waco, TX United States
  Connect »

Mikaela Grupp

Octapharma Research Site
Richmond, VA United States
  Connect »

Mikaela Grupp

Mid-Columbia Research
Richland, WA United States
  Connect »

Mikaela Grupp

Uniklinikum Marburg, Allergologie
Marburg, Germany
  Connect »

Mikaela Grupp

Octapharma Research Site
Montréal, QC Canada
  Connect »

Mikaela Grupp

Unimedizin G ttingen, Abteilung Neurologie
Göttingen, Germany
  Connect »

Mikaela Grupp

Uniklinikum M nster, Klinik f r Hautkrankheiten
Münster, Germany
  Connect »

Mikaela Grupp

Centrum Medyczne Plejady
Kraków, Poland
  Connect »